STAT - Reporting from the frontiers of health and medicine

Health Tech

Health

Biotech

Health Nursing homes grapple with a dual crisis: preparing for hurricane season amid the Covid-19 pandemic
Health Tech 10 burning questions about Teladoc’s $18.5 billion deal to buy Livongo
The Readout LOUD The story of a scientist’s mea culpa on Covid-19 vaccines — and a rough week on Twitter
Biotech The FDA accepted Biogen’s Alzheimer’s drug submission. Next up, a highly anticipated outside expert review
Pharmalot AbbVie pays $24 million to settle lawsuit over using ‘nurse ambassadors’ to boost Humira sales

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

Hospital president wrote opinion piece critical of drug pricing efforts, but didn’t disclose role on Moderna board
Up and down the ladder: The latest comings and goings
Pharmalittle: Trump’s ‘Buy American’ order raises doubts; Gilead looks to boost global remdesivir output

Health

Health Tech

Health

Special Report

Health

On the Front Lines

Health ‘A huge experiment’: How the world made so much progress on a Covid-19 vaccine so fast
Health The Covid-19 Tracker
Health Tech As mindfulness app Headspace booms, its popularity outpaces its scientific evidence
Health ‘We don’t actually have that answer yet’: WHO clarifies comments on asymptomatic spread of Covid-19
Health Covid-19 infections leave an impact on the heart, raising concerns about lasting damage
Biotech The FDA accepted Biogen’s Alzheimer’s drug submission. Next up, a highly anticipated outside expert review
Politics Trump orders government to buy certain drugs solely from U.S. factories, setting up major shakeup for industry
In the Lab ‘Microdosing’ is touted by ’shroomers and Reddit users. Science is starting to test their claims — and finding some truth